Some studies found that the loss of DNMT3B accelerated MLL-AF9 leukemia progression.172 Others showed that high expression of DNMT3B contributed to abnormal DNA methylation and MYC-driven tumor development in T-ALL and BL.65 Here, DNMT3B is linked to neoplasm.